This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Fragment Screening Remove Pharmacokinetics Remove Treatment Related Topics
Biochemical Assays Drug Development Disease Virus Vaccine Drugs Therapies Trials Research Hospitals More Related Topics >
article thumbnail

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

PerkinElmer

JUNE 3, 2022

Viral protease inhibitors that block enzymes critical for viral replication have long been used in the treatment of human immunodeficiency (HIV) and hepatitis C viruses. Researchers are now studying the potential of protease inhibitors for the treatment of SARS-CoV-2. For research use only. Not for use in diagnostic procedures.

Fragment Screening 52
Fragment Screening Clinical Trials Vaccine Pharmacokinetics 52
article thumbnail

SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments

Molecular Design

JULY 18, 2020

While I’m not particularly keen on the use of the term ‘open source’ in this context, I have absolutely no quibble with the goal of seeking cures and treatments for diseases that are ignored by commercial drug discovery organizations.

Biochemical Assays 52
Biochemical Assays Fragment Screening Pharmacokinetics Drugs 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024